FOLD icon

Amicus Therapeutics

257 hedge funds and large institutions have $2.74B invested in Amicus Therapeutics in 2021 Q1 according to their latest regulatory filings, with 52 funds opening new positions, 96 increasing their positions, 77 reducing their positions, and 63 closing their positions.

New
Increased
Maintained
Reduced
Closed

more repeat investments, than reductions

Existing positions increased: | Existing positions reduced:

more call options, than puts

Call options by funds: $ | Put options by funds: $

less ownership

Funds ownership:

less funds holding

Funds holding:

17% less funds holding in top 10

Funds holding in top 10: 65 (-1)

17% less first-time investments, than exits

New positions opened: 52 | Existing positions closed: 63

58% less capital invested

Capital invested by funds: $6.44B → $2.74B (-$3.71B)

Holders
257
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
5
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$26.6M
Puts
$21.6M
Net Calls
Net Calls Change

Top Sellers

1 -$154M
2 -$31.2M
3 -$31.1M
4
Morgan Stanley
Morgan Stanley
New York
-$27.3M
5
D.E. Shaw & Co
D.E. Shaw & Co
New York
-$26.3M
Name Holding Trade Value Shares
Change
Change in
Stake
151
$362K
152
$355K
153
$347K
154
$347K
155
$333K
156
$317K
157
$296K
158
$290K
159
$289K
160
$259K
161
$258K
162
$258K
163
$248K
164
$246K
165
$246K
166
$244K
167
$241K
168
$228K
169
$226K
170
$214K
171
$210K
172
$207K
173
$207K
174
$203K
175
$197K